FR2598422B1 - Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant - Google Patents

Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant

Info

Publication number
FR2598422B1
FR2598422B1 FR8606704A FR8606704A FR2598422B1 FR 2598422 B1 FR2598422 B1 FR 2598422B1 FR 8606704 A FR8606704 A FR 8606704A FR 8606704 A FR8606704 A FR 8606704A FR 2598422 B1 FR2598422 B1 FR 2598422B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
glutamyl
pseudo
peptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8606704A
Other languages
English (en)
Other versions
FR2598422A1 (fr
Inventor
Arielle Ungerer
Jean De Barry
Yves Louis Jacques Boulanger
Monique Schmitz-Bourgeois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR8606704A priority Critical patent/FR2598422B1/fr
Priority to PCT/FR1987/000151 priority patent/WO1987006931A1/fr
Priority to US07/153,834 priority patent/US4975418A/en
Priority to JP62502979A priority patent/JPH01500590A/ja
Priority to EP87902565A priority patent/EP0266385A1/fr
Publication of FR2598422A1 publication Critical patent/FR2598422A1/fr
Application granted granted Critical
Publication of FR2598422B1 publication Critical patent/FR2598422B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8606704A 1986-05-09 1986-05-09 Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant Expired FR2598422B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR8606704A FR2598422B1 (fr) 1986-05-09 1986-05-09 Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant
PCT/FR1987/000151 WO1987006931A1 (fr) 1986-05-09 1987-05-07 Pseudo-peptide therapeutiquement actif d'acide glutamyl-aspartique
US07/153,834 US4975418A (en) 1986-05-09 1987-05-07 Therapeutically active compositions of pseudo-peptide of glutamyl-aspartic acid
JP62502979A JPH01500590A (ja) 1986-05-09 1987-05-07 少くともグルタミル‐アスパラギン酸の配列を含むプソイドペプチド又はその誘導体の一つ、医薬品組成物の調製におけるその利用とその結果得られる医薬組成物
EP87902565A EP0266385A1 (fr) 1986-05-09 1987-05-07 Pseudo-peptide therapeutiquement actif d'acide glutamyl-aspartique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8606704A FR2598422B1 (fr) 1986-05-09 1986-05-09 Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant

Publications (2)

Publication Number Publication Date
FR2598422A1 FR2598422A1 (fr) 1987-11-13
FR2598422B1 true FR2598422B1 (fr) 1989-12-08

Family

ID=9335079

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8606704A Expired FR2598422B1 (fr) 1986-05-09 1986-05-09 Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant

Country Status (5)

Country Link
US (1) US4975418A (fr)
EP (1) EP0266385A1 (fr)
JP (1) JPH01500590A (fr)
FR (1) FR2598422B1 (fr)
WO (1) WO1987006931A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284972A (en) * 1993-06-14 1994-02-08 Hampshire Chemical Corp. N-acyl-N,N',N'-ethylenediaminetriacetic acid derivatives and process of preparing same
JP5784295B2 (ja) * 2010-09-28 2015-09-24 国立大学法人 岡山大学 新規分岐状アミノ酸、新規分岐状アミノ酸と蛍光性アミノ酸の複合体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500019A (en) * 1946-10-08 1950-03-07 Frederick C Bersworth Method of producing polycarboxylic amino acids
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
FR2558471B1 (fr) * 1984-01-19 1987-11-20 Isochem Sa Procede de preparation d'aspartyl peptides, et nouveaux intermediaires de synthese
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides

Also Published As

Publication number Publication date
US4975418A (en) 1990-12-04
JPH01500590A (ja) 1989-03-01
EP0266385A1 (fr) 1988-05-11
FR2598422A1 (fr) 1987-11-13
WO1987006931A1 (fr) 1987-11-19

Similar Documents

Publication Publication Date Title
FR2604357B1 (fr) Composition pharmaceutique et cosmetique anti-acneique
BR8602005A (pt) Composicao tenso-ativa,processo de preparacao da composicao tenso-ativa e suspensao de ou das materias ativas
TR22628A (tr) Butadien'in polimerizasyonu veya kopolimerizasyonu icin islah edilmis usul
MX17734A (es) Dieteres empleados en la preparacion de catalizadores ziegler-natta.
TR22613A (tr) Butadien'in polimerizasyonu veya kopolimerizasyonu icin islah edilmis usul
NZ222133A (en) N #alpha# -(#alpha#-glucosyl(1-4)-deoxyfructosyl)-octreotide and pharmaceutical compositions
KR880701771A (ko) 액상 중합체 조성물 및 그의 용도
IL82671A0 (en) 1,5-diaryl-3-substituted-pyrazoles,their preparation and pharmaceutical compositions containing them
FR2633182B1 (fr) Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
KR880700831A (ko) 아릴사이클로부텐-함유 조성물 및 이로부터 제조한 중합조성물
KR880701750A (ko) Uv-흡수 축합 중합체 조성물 및 이의 생성물
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
IL84832A (en) 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3- ones, their preparation and pharmaceutical compositions containing them
BR8702978A (pt) Aplicacao de 3-acilamino-1,2,4-triazois e/ou de 1-acil-3-amino-1,2,4-triazois
EP0243616A3 (en) Liquid preparations of 1,2-benzisothiazol-in-3-one
IT8521002A0 (it) 4' -desclororebeccamicina eprocedimento per la sua preparazione.
FR2573760B1 (fr) Composes derives du cholecalciferol, composition pharmaceutique antitumorale et utilisation desdits composes dans la preparation de cette composition pharmaceutique
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
BR8707454A (pt) Gel po's-espumante contendo determinada dialcanolamida ou monoalcanolamida
MC1847A1 (fr) Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
FR2598617B1 (fr) Composition pharmaceutique
FR2598422B1 (fr) Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant
IT8620796A0 (it) Processo per la preparazione dell'n-dimetilchitosano e suoi impieghi farmacologici.

Legal Events

Date Code Title Description
ST Notification of lapse